OTCMKTS:ECIAEncision Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Encision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.48 -0.02 (-4.00 %) (As of 07/31/2020 04:00 PM ET) Add Compare Share Today's Range$0.48Now: $0.48▼$0.4850-Day Range$0.40MA: $0.62▼$0.6852-Week Range$0.35Now: $0.48▼$0.95Volume1,000 shsAverage Volume5,232 shsMarket Capitalization$5.56 millionP/E RatioN/ADividend YieldN/ABeta-0.39 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The company's AEM instruments product line includes a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also provides various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; and AEM Burn Protection Cable, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was founded in 1991 and is based in Boulder, Colorado.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Encision. Previous Next 2.5 Community Rank Outperform VotesEncision has received 81 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEncision has received 83 “underperform” votes. (Add your “underperform” vote.)Community SentimentEncision has received 50.61% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Encision and other stocks. Vote “Outperform” if you believe ECIA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ECIA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEncision does not currently pay a dividend.Dividend GrowthEncision does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Encision insiders have bought more of their company's stock than they have sold. Specifically, they have bought $39,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders38.16% of the stock of Encision is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Encision is -24.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Encision is -24.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEncision has a P/B Ratio of 2.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.30 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ECIA Previous Symbol CUSIPN/A CIK930775 Webwww.encision.com Phone303-444-2600Debt Debt-to-Equity RatioN/A Current Ratio2.11 Quick Ratio0.95Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.67 million Price / Sales0.72 Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book2.53Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-200,000.00 Net Margins-2.58% Return on Equity-8.93% Return on Assets-4.45%Miscellaneous Employees36 Outstanding Shares11,580,000Market Cap$5.56 million Next Earnings Date8/10/2020 (Estimated) OptionableNot Optionable $0.48 -0.02 (-4.00 %) (As of 07/31/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ECIA News and Ratings via Email Sign-up to receive the latest news and ratings for ECIA and its competitors with MarketBeat's FREE daily newsletter. Encision (OTCMKTS:ECIA) Frequently Asked Questions How has Encision's stock been impacted by COVID-19 (Coronavirus)? Encision's stock was trading at $0.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ECIA shares have decreased by 20.0% and is now trading at $0.48. View which stocks have been most impacted by Coronavirus. When is Encision's next earnings date? Encision is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Encision. How were Encision's earnings last quarter? Encision, Inc. (OTCMKTS:ECIA) issued its earnings results on Thursday, May, 14th. The medical device company reported ($0.01) EPS for the quarter. The medical device company earned $1.78 million during the quarter. Encision had a negative return on equity of 8.93% and a negative net margin of 2.58%. View Encision's earnings history. Has Encision been receiving favorable news coverage? Media headlines about ECIA stock have been trending negative recently, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Encision earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news stories about the medical device company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Encision. Who are some of Encision's key competitors? Some companies that are related to Encision include Biostage (BSTG), Avinger (AVGR), Hypertension Diagnostics (HDII), Dynatronics (DYNT), PlusTherapeuticsInc . (PSTV), Lianluo Smart (LLIT), Hancock Jaffe Laboratories (HJLI), Invivo Therapeutics (NVIV), CELLECT BIOTECH/S (APOP), Obalon Therapeutics (OBLN), Neurometrix (NURO), RA Medical Systems (RMED), Cytocore (MDIT), Calmare Therapeutics (CTTC) and Regenicin (RGIN). View all competitors. What other stocks do shareholders of Encision own? Based on aggregate information from My MarketBeat watchlists, some companies that other Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), NovaBay Pharmaceuticals (NBY), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), Allegheny Technologies (ATI), Digital Turbine (APPS), Allstate (ALL) and Achaogen (AKAO). Who are Encision's key executives? Encision's management team includes the following people: Mr. Gregory J. Trudel, CEO, Pres & Director (Age 58)Mr. David W. Newton, Co-Founder, VP of Technology & Director (Age 72)Mr. Peter Geary, VP of Operations (Age 61)Ms. Mala Ray, VP, Controller, Treasurer, Sec., Principal Accounting Officer & Principal Financial Officer (Age 60)Mr. Brian Jackman, Director of Marketing What is Encision's stock symbol? Encision trades on the OTCMKTS under the ticker symbol "ECIA." How do I buy shares of Encision? Shares of ECIA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Encision's stock price today? One share of ECIA stock can currently be purchased for approximately $0.48. How big of a company is Encision? Encision has a market capitalization of $5.56 million and generates $7.67 million in revenue each year. Encision employs 36 workers across the globe. What is Encision's official website? The official website for Encision is www.encision.com. How can I contact Encision? Encision's mailing address is 6797 WINCHESTER CIRCLE, BOULDER CO, 80301. The medical device company can be reached via phone at 303-444-2600. This page was last updated on 8/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
